PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Elvin Blanco, Haifa Shen, Mauro Ferrari · Nature Biotechnology · 2015 · 6.7K citations · Full text

Pharmacy, Biomedical Engineering, Pharmaceutics +16

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake

Carl Walkey, Jonathan B. Olsen, Hongbo Guo et al. · Journal of the American Chemical Society · 2011 · 1.9K citations

Natural Sciences, Immunology, Materials Science +17

Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies

Tae‐You Kim, Dong-Wan Kim, Jae‐Yong Chung et al. · Clinical Cancer Research · 2004 · 804 citations

Medicine, Oncology, Pharmacology +14

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

Tamar Safra, Franco M. Muggia, Susan Jeffers et al. · Annals of Oncology · 2000 · 613 citations

Pharmacy, Pharmacokinetics, Pharmacology +16